# Graphene oxide size and oxidation degree govern its supramolecular interactions with siRNA

Giacomo Reina, Ngoc Do Quyen Chau, Yuta Nishina, Alberto Bianco

► To cite this version:

Giacomo Reina, Ngoc Do Quyen Chau, Yuta Nishina, Alberto Bianco. Graphene oxide size and oxidation degree govern its supramolecular interactions with siRNA. Nanoscale, 2018, 10 (13), pp.5965-5974. 10.1039/c8nr00333e. hal-02328000

HAL Id: hal-02328000

https://hal.science/hal-02328000v1

Submitted on 28 Feb 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>
<figure><img src="image_2.png" /></figure>

Cite this: Nanoscale, 2018, **10**, 5965

# Graphene oxide size and oxidation degree govern its supramolecular interactions with siRNA†

Giacomo Reina, ID *a* Ngoc Do Quyen Chau,ª Yuta Nishina ID b,c and
Alberto Bianco ID *a

Several studies have demonstrated the ability of graphene oxide (GO) to efficiently adsorb small-interfering RNA (siRNA) on its surface and to transport it into cells. However, studies on whether and how siRNA interacts with GO are still inconclusive. In this context, understanding the interaction between GO and siRNA is fundamental to design new efficient gene silencing tools. In this work, the interactions between GO and siRNA molecules were systematically investigated. We focused on how the GO size, oxygenated groups present on the surface and chemical functionalization affect the double helix siRNA structure, using gel electrophoresis, UV-Vis spectroscopy, fluorescence resonance energy transfer (FRET) and circular dichroism (CD). We found that the siRNA secondary structure was clearly altered by the interaction with GO flakes. In addition, we were able to correlate the double strand damage with the size and the oxygenated groups present on the GO sheets. Finally, we demonstrated that GO functionalized with low molecular weight polyethyleneimine (PEI, 800 Da) is able to protect siRNA from structural modifications. We believed that this research effort will improve our understanding of the behavior of GO/siRNA complexes, and thus facilitate the design of appropriate bio/nanointerfaces and new efficient gene silencing systems.

Received 12th January 2018,
Accepted 11th February 2018

DOI: 10.1039/c8nr00333e

rsc.li/nanoscale

## 1. Introduction

In the last few decades, owing to the promising capability in the treatment of many diseases, gene therapy has gained tremendous attention. This type of therapeutic modality is based on the delivery of a variety of exogenous nucleic acids such as plasmid DNA, mRNA, siRNA, microRNA or antisense oligonucleotides.¹,² Among the different strategies, RNA interference (RNAi) in gene silencing has been rapidly recognized as one of the most exciting and revolutionary approaches in the specific knockdown of the target gene because of its simple and rapid mechanism.³,⁴ Indeed, the induction of RNAi is mediated by siRNA, a class of double strand RNA composed of 19–25 base pairs in length. Upon the incorporation into a RNA-induced silencing complex, this synthetic sequence can bind the complementary RNA, which triggers the target mRNA degradation, thus inhibiting the

specific protein expression.⁵,⁶ However, the delivery of siRNA to target cells has inherent drawbacks mainly due to the siRNA instability, and low transfection efficiency, biocompatibility and biodistribution.⁷ Therefore, the development of effective and non-toxic delivery systems is crucial to overcome the barrier between the potential of gene silencing and a real therapeutic application.

Due to its unique physicochemical and structural properties, its electrical and optical characteristics and biodegradability, graphene and its derivatives have attracted increasing interest as a prominent potential vector in gene delivery.⁸⁻¹¹ In particular, graphene oxide, the oxidized and water soluble form of graphene, offers a wide opportunity to load both hydrophilic and hydrophobic molecules and different target species on its large surface area.¹² Studies of the interactions of GO with nucleic acids have been substantially enhanced over the past few years for the application in biosensing, diagnostics and biomedicine.¹³⁻¹⁵ Generally, the binding between GO and single strand DNA (ssDNA) or single strand RNA (ssRNA) is ascribed either to the π–π stacking or the hydrogen bonding and van der Waals forces.¹⁶ In the case of double strand DNA (dsDNA), Lei et al.¹⁷ have figured out that DNA can bind GO to form a dsDNA/GO complex in the presence of a high concentration of salts via electrostatic interactions. Liu et al.¹⁸ also reported the salt-controlled assembly of graphene sheets to capture dsDNA in high salt concentration. In contrast, Tang et al.,¹⁹ by measuring the quenching effect between

<figure><img src="image_3.png" /></figure>

<footnote>ªUniversity of Strasbourg, CNRS, Immunology, Immunopathology and Therapeutic Chemistry, UPR 3572, 67000 Strasbourg, France.</footnote>

<footnote>E-mail: a.bianco@ibmc-cnrs.unistra.fr, g.reina@ibmc-cnrs.unistra.fr</footnote>

<footnote>ᵇPrecursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan</footnote>

<footnote>ᶜResearch Core for Interdisciplinary Sciences, Okayama University, Tsushimanaka, Kita-ku, Okayama 700-8530, Japan</footnote>

<footnote>†Electronic supplementary information (ESI) available. See DOI: 10.1039/c8nr00333e</footnote>
<figure><img src="image_4.png" /></figure>

a fluorescently-labeled dsDNA and GO, proved that there is no effect of salt on fluorescence change, thus excluding the electrostatic interactions as the major driving force for dsDNA on the surface of GO. Moreover, this study explored for the first time the partial deformation of dsDNA incubated with GO. The GO induced deformation of dsDNA had been previously predicted by molecular dynamics simulation studies, showing that the hydrophobic π-π stacking between GO and dsDNA had a dominant role in the DNA structure alteration.²⁰ On the other hand, Ren et al.²¹ suggested that GO can intercalate efficiently into DNA molecules and enhance the double strand cleavage activity of copper ions *via* a mechanism based on an oxidative and hydrolytic effect. Besides, another study proved that the DNA cleavage induced by GO and reduced GO with a different Cu²⁺ complex was triggered by interaction of GO with DNA.²² Despite these studies, understanding deeply how the conformation of double strand siRNA is affected by GO remains ambiguous. A thorough comprehension of the mechanism of interaction between GO and siRNA is crucial for application of GO in future clinical settings. For these reasons, we performed various spectroscopic investigations demonstrating that non-functionalized GO significantly alters the double strand native structure. In particular, small GO flakes seem to intercalate inside the double strand, breaking some of the base to base hydrogen bonds (H-bonds). On the other hand, large GO flakes alter mainly the secondary structure geometry interacting mostly with the helix groove and causing the winding angle relaxation. Interestingly, PEI functionalized GO is able to avoid siRNA double strand structural modifications and to sensibly enhance siRNA adsorption on GO sheets.

## 2. Materials and methods

### 2.1. Materials

Polyethyleneimine (PEI) (MW 800 Da), was purchased from Sigma Aldrich. The solvents were obtained from commercial suppliers and used without purification. Water was purified using a Millipore filter system MilliQ® and free endotoxin Polisseur Biopak®. When stated, suspensions were sonicated in a water bath (20 W, 40 kHz). The filtration and dialysis membranes were purchased from Millipore and Spectrum Laboratories, Inc., respectively.

In this experiment, Yakima labeled siRNA (sUGC-GCU-ACG-AUC-GACGAU-G55), siRNA labeled at the 5' position with Alexa Fluor®546, siRNA with one strand labeled at the 5' position with Alexa Fluor®546 (donor) and the other strand labeled at the 5' position with Alexa Fluor®647 (acceptor), siRNA labeled at the 5' position with Cy®3, and siRNA with one strand labeled at the 5' position with Cy®3 (donor) and the other strand marked at the 3' position with Cy®5 (acceptor) were purchased from Eurogentec.

### 2.2. Instruments

Thermogravimetric analysis (TGA) was performed on a TGA1 (Mettler Toledo) apparatus from 30 °C to 900 °C with a ramp

of 10 °C min⁻¹ under N₂ using a flow rate of 50 mL min⁻¹ and platinum pans. X-ray Photoelectron Spectroscopy (XPS) analyses were performed on a Thermo Scientific K-Alpha X-ray photoelectron spectrometer with a basic chamber pressure of 10⁻⁸–10⁻⁹ bar with an anode using Al Kα radiation (hν = 1486.6 eV). The C (1s) photoelectron binding energy was set at 284.5 ± 0.2 eV and used as a reference for calibrating the other peak positions. The samples were analyzed as powder. A spot size of 400 µm was used. The survey spectra are the average of 10 scans with a pass energy of 200.00 eV and a step size of 1 eV. The high-resolution spectra are an average of 10 scans with a pass energy of 50 eV and a step size of 0.1 eV. An ion gun was turned on during analysis. For each sample, the analysis was repeated three times. X-ray diffraction was carried out by using a PANalytical Co. X'Pert PRO using Cu Kα radiation (λ = 1.541 Å) in the 2θ range of 5–20°. The operating tube current and voltage were 40 mA and 40 kV, respectively. Ozone treatment was performed using an ozone generator (Ozone Wave Pro, Syoken Co. Ltd). SEM measurement was performed on a SEM S-5200 (Hitachi High Technologies Corporation, Tokyo, Japan). UV-Vis absorption spectra were recorded on a Cary 5000 UV-Vis-NIR spectrophotometer and were corrected for the baseline and the solvent. Steady-state luminescence experiments were performed with a Fluoromax-4 spectrophotometer (Horiba-Jobin-Yvon Inc.). Emission spectra were corrected for the monochromator and detector efficiency and for the light source intensity (450 W xenon arc lamp), employing standard correction files and recording the reference signal. Circular dichroism (CD) spectra have been recorded with a J-810 Jasco spectropolarimeter. Each spectrum was recorded at 1 nm resolution after 16 accumulations from 190 to 350 nm. Filtration was performed using a Sterile Millex® (13 mm) filter unit with a Durapore® membrane and a pore size of 0.22 µm. HPLC analyses were performed on a Waters HPLC system (Waters Co., Milford, MA, USA) equipped with a reversed-phase C-18 column system with an analytical C18 column (EC 150/4.6 NUCLEOSIL 100-5 C18 length: 150 mm, ID: 4.6 mm, 5 µm). The following solvent system was used: solvent A, 0.1 M trimethylammonium acetate at pH 7.5 and solvent B, acetonitrile. Gradient elution was applied at a flow rate of 2 mL min⁻¹ for 60 min. The chromatograms were recorded following the absorption maximum of Alexa Fluor®647-labeled siRNA at 650 nm.

### 2.3. Preparation of graphene oxide with different oxygen percentages and their PEI functionalization

Large graphene oxide (GO_L) was synthesized following the modified Hummers method by the group of Nishina²³ and obtained as an aqueous dispersion of GO. Small graphene oxide (GO_S) was obtained from the company Nanoinnova as a powder. Reduced GO with different oxygen percentages was synthesized as mentioned in our previous report.²⁴ Briefly, rGO_L and rGO_S were obtained from GO_L and GO_S, respectively, heated and refluxed at 100 °C for 5 days with continuous stirring, washed with dimethylformamide (DMF), methanol (MeOH), and dichloromethane (DCM), dialyzed
<figure><img src="image_5.png" /></figure>

against Milli-Q water and lyophilized. rGO<sub>L</sub>-O<sub>3</sub> and rGO<sub>S</sub>-O<sub>3</sub> were obtained by fluxing O<sub>3</sub>, which was generated from an air source, to a suspension of rGO<sub>L</sub> and rGO<sub>S</sub>, respectively, in water at room temperature for 3 h at a flow rate of 2 ml min<sup>-1</sup>; then the products were washed with DMF, MeOH, and DCM, dialyzed against Milli-Q water and lyophilized. PEI functionalized GO/rGO was obtained after an addition of PEI to a suspension of the corresponding GO/rGO with a mass ratio of 1:1. The reaction mixture was stirred for 3 days, then centrifuged until the pH of the supernatant was neutral. Finally PEI functionalized GO/rGO was dialyzed against water (Spectra/ Por® dialysis membrane MWCO 12 000–14 000 Da) for 3 days and lyophilized.

## 2.4. Evaluation of siRNA/GO complexation by agarose gel electrophoresis mobility assay

A solution of double-stranded Yakima-labeled siRNA ($C = 0.1 \mu g \mu l^{-1}$) was kept constant at 2 µl in every mass ratio. The suspensions of different GO and PEI-GO in Milli-Q® RNAse-free water were prepared corresponding to each mass ratio GO/ siRNA required for the complexation with siRNA. The suspensions were kept at room temperature for 30 min to allow the formation of the complexes. After staining with Orange DNA loading dye (6×, Thermo Fisher Scientific) (total loading sample volume = 30 µL), the suspensions were added to 2% agarose containing GelRed (Biotium, USA) followed by electrophoresis in Tris-Acetate-EDTA (TAE) buffer at 100 mV for 30 min. The gels were then visualized under UV light using the Gel Doc™ EZ Imager – Bio-Rad and Image lab software. The signal of each experiment was normalized to the signal of the free siRNA as a control and subtracted by the background signal by using the ImageJ program. Each experiment was repeated at least three times.

## 2.5. Preparation of the solutions for spectroscopic analyses

For dynamic equilibrium experiments using CD, 180 µl of siRNA labeled Yakima ($C = 0.1 \mu g \mu l^{-1}$, $m = 18 \mu g$) and a suspension of 12 µl of GO ($C = 3 \mu g \mu l^{-1}$, $m = 36 \mu g$) (GO/siRNA ratio: 2) were added to 258 µl of Milli-Q® RNAse-free water. The helicity was calculated by normalizing the signal to the cuvette length (0.2 cm) and the molar concentration.

For CD and UV, to 180 µl of siRNA labeled Yakima ($C = 0.1 \mu g \mu l^{-1}$, $m = 18 \mu g$), 270 µl of Milli-Q® RNAse-free water was added to obtain 450 µl of siRNA solution ($C' = 40 \mu g \mu l^{-1}$) as a control. A calibration of siRNA signal in UV with concentrations from 10 µg ml<sup>-1</sup> to 50 µg ml<sup>-1</sup> was also performed. At a mass ratio of GO/siRNA equal to 20, to 180 µl of siRNA ($C = 0.1 \mu g \mu l^{-1}$, $m = 18 \mu g$), a suspension of 72 µl of GO ($C = 5 \mu g \mu l^{-1}$, $m = 360 \mu g$) and 198 µl of Milli-Q® RNAse-free water were added to obtain a solution of siRNA at the same concentration as the control. After the interaction of GO with siRNA, the helicity was calculated by normalizing the signal to the cuvette length (0.2 cm) and the molar concentration obtained from the Yakima signal at 523 nm in UV.

For the FRET analysis, to 60 µl of each siRNA (siRNA labeled Cy3, siRNA labeled Cy3/Cy5, siRNA labeled Alexa

Fluor®546, siRNA labeled Alexa Fluor®546/Alexa Fluor®647, $C = 0.1 \mu g \mu l^{-1}$, $m = 6 \mu g$), 90 µl of Milli-Q® RNAse-free water was added to obtain separately 150 µl of siRNA solution ($C' = 40 \mu g \mu l^{-1}$) as a control. At a mass ratio of GO/siRNA equal 20, to 60 µl of siRNA ($C = 0.1 \mu g \mu l^{-1}$, $m = 6 \mu g$), a suspension of 24 µl of GO ($C = 5 \mu g \mu l^{-1}$, $m = 120 \mu g$) and 66 µl of Milli-Q® RNAse-free water were added to obtain a solution of siRNA at the same concentration as the control. After the interaction of siRNA with GO, the filtered siRNA solutions were excited at 535 nm and the maximum was recorded at 570 and 575 nm for Alexa 546 and Cy3, respectively. The FRET efficiency was calculated by normalizing for the absorbance of each solution at 535 nm (measured by UV-Vis). Statistical analyses were performed using an unpaired *t*-test.

## 2.6. Preparation of the solutions for HPLC analyses

For HPLC analysis, 100 µl of Milli-Q® RNAse-free water was added to 100 µl of siRNA (siRNA labeled Alexa Fluor®647, $C = 0.1 \mu g \mu l^{-1}$, $m = 10 \mu g$) to obtain 200 µl of siRNA solution as a control. For the denaturation of siRNA, 100 µl of a solution of 2% of formaldehyde in Milli-Q® RNAse-free water was added to 100 µl of siRNA (siRNA labeled Alexa Fluor®647, $C = 0.1 \mu g \mu l^{-1}$, $m = 10 \mu g$) to obtain 200 µl of final solution. Subsequently, the solution was heated at 95 °C for 1 min and immediately cooled down using an ice bath. In the case of the analysis of the sample prepared at the mass ratio of GO/siRNA equal to 20, a suspension of 66.7 µl of GO ($C = 3 \mu g \mu l^{-1}$, $m = 200 \mu g$) and 33.3 µl of Milli-Q® RNAse-free water were added to 100 µl of siRNA ($C = 0.1 \mu g \mu l^{-1}$, $m = 10 \mu g$) to obtain a solution of siRNA at the same concentration as the control. After the interaction of siRNA with GO, the filtered siRNA solutions were injected in HPLC.

# 3. Results and discussion

## 3.1 Preparation and characterization of non-functionalized and PEI-functionalized GO materials

The aim of this work was to elucidate the mechanism of the interaction between siRNA molecules and GO flakes. For this purpose the lateral size, oxygenated groups and functionalization effects were taken into consideration. We decided to use two different samples of academic (named GO<sub>L</sub>) and commercial (named GO<sub>S</sub>) sources, both prepared by the Hummers method.²³ The two GO materials are prepared by a slightly different process, as they differ in the percentage of oxygenated groups and lateral sizes. The lateral sizes of two GO samples correspond to 300 ± 200 nm in the case of GO<sub>S</sub> (Fig. S1 in the ESI†) and 3 ± 1 µm for GO<sub>L</sub>. To understand how the oxygenated groups affect the siRNA structure, we decided to perform a reduction and a subsequent epoxidation of the graphene oxide materials. Reduced GO<sub>S</sub> (rGO<sub>S</sub>) and GO<sub>L</sub> (rGO<sub>L</sub>) were prepared under green conditions without using any toxic reagents. Epoxidation reaction was performed on rGO<sub>S</sub> and rGO<sub>L</sub> using O<sub>3</sub> under the same conditions reported before.²⁴ In addition, aiming to study the effect of amino functionali-
<table><caption>**Table 1** Different GO materials used in this study and C/O ratios of non-functionalized GO obtained by XPS analysis</caption><thead><tr><th rowspan="2"></th><th colspan="3">Small GO</th><th colspan="3">Large GO</th></tr><tr><th>Starting material</th><th>Hydrothermal reduction</th><th>Epoxidation</th><th>Starting material</th><th>Hydrothermal reduction</th><th>Epoxidation</th></tr></thead><tbody><tr><td>Non-functionalized (C/O ratio)</td><td>GO<sub>S</sub> (2.2 ± 0.1)</td><td>rGO<sub>S</sub> (3.5 ± 0.2)</td><td>rGO<sub>S</sub>-O<sub>3</sub> (2.6 ± 0.1)</td><td>GO<sub>L</sub> (2.6 ± 0.1)</td><td>rGO<sub>L</sub> (6.1 ± 0.1)</td><td>rGO<sub>L</sub>-O<sub>3</sub> (3.5 ± 0.1)</td></tr><tr><td>PEI-functionalized</td><td>GO<sub>S</sub>-PEI</td><td>rGO<sub>S</sub>-PEI</td><td>rGO<sub>S</sub>-O<sub>3</sub>-PEI</td><td>GO<sub>L</sub>-PEI</td><td>rGO<sub>L</sub>-PEI</td><td>rGO<sub>L</sub>-O<sub>3</sub>-PEI</td></tr></tbody></table>

zation, all prepared materials have been functionalized with polyethylenimine (PEI) via an epoxy ring opening reaction.²⁵ In Table 1, the list of the different samples tested for siRNA binding is reported.

In order to measure the level of functionalization, we assessed the thermal profiles of the series of GOs and GOL by TGA (Fig. S2, ESI†).²⁴ The TGA curve of GOs [Fig. S2(a), ESI†] shows the typical decomposition features of the GO material. The first mass decrease below 120 °C can be ascribed to the loss of physisorbed water molecules, while the significant mass loss between 120 and 250 °C is related to the decomposition of the oxygenated groups on the GO sheets. A similar trend can be seen in the TGA curves of rGOs and rGOs-O3 [Fig. S2(b) and (c), respectively in the ESI†], but with a different percentage in mass loss. Indeed, compared to GOs, rGOs shows a less pronounced decomposition in the range between 120 and 250 °C, while rGOs-O3 mass loss, in the same temperature range, is between rGOs and GOs. This behavior is related to the reduction/oxidation treatment performed on the sample. In fact, the hydrothermal process on GOs leads to oxygen depletion, while the rGOs epoxidation restores some oxygenated groups on the nanostructure as supported by the higher loss above 250 °C in the rGOs-O3 thermogram. As previously described, a different trend was observed in the TGA curve in the case of GOL during the oxidation and reduction treatments.²⁴ Additional characterization was performed by XPS. This analysis (Table 1 and Fig. S3 and S4 in the ESI†) showed similar values for both GOs and GOL. The calculated C/O ratio around 2.5 is typical of most of the GO materials.²⁶ The hydrothermal reduction process allowed diminishing the oxygen content on the GO surface. In particular, the hydrothermal treatment of rGOs and rGOL afforded materials with C/O ratios of 3.5 and 6.1, respectively. The decrease of 0% is more evident in the case of GOL than in GOs. This behavior may be attributed to a different reactivity due to the lateral size; more stable oxygenated groups such as carbonyl groups are predominant for GOs. Ozone treatment caused a decrease of C/O ratio to 2.6 in rGOs-O3 and to 3.5 in rGOs-O3, proving the successful epoxidation of the graphene sheets. Moreover, the increase in the C-O band in the case of rGOs-O3 (Fig. S4c in the ESI†) and rGOs-O3²⁴ proved that the ozone treatment is able to introduce new epoxide groups on the GO surface.

Following the preparation and characterization of GO with different oxygen contents, we functionalized them with low molecular weight PEI to clarify the role of amino groups in terms of interaction with double strand siRNA. The thermal

profile of the amino functionalized GO was assessed by TGA (Fig. S5, ESI†).²⁴ After PEI functionalization, all samples displayed a higher mass loss above 350 °C related to the degradation of the polymer chains. XPS analysis of PEI-functionalized GO was also performed. The appearance of a peak corresponding to N 1s (Fig. S3b in the ESI†) suggested the successful amino derivatization of the GO sheets (Table S1 in the ESI†). To better understand the effect of oxygenation and functionalization of GO, X-ray diffraction (XRD) characterization was conducted on the small GOs samples (Fig. S6 and Table S2 in the ESI†). Starting GOs shows a peak centered at 2θ = 11.6° corresponding to a distance of 7.6 Å. This value is typical of GO nanostructures,²⁷ and is attributed to the [002] interplanar distance in the GO lattice. Reduction and epoxidation processes led to a shift of the [002] XRD peak maximum up to 2θ = 12.9° and 12.8° for rGOs and rGOs-O3, respectively. The changes detected in the sheet to sheet distances can be ascribed to the variation in the oxygen content on the sample surface.²⁷ Indeed, the hydrothermal reduction depletes oxygen from the GO surface causing a diminution in the average layer to layer distance to 6.8 Å, while rGOs epoxidation causes a small increase up to 6.9 Å. In the case of PEI functionalized GOs materials, the interplanar distance increased to 9.3 Å, which is attributed to the grafting of the polymer chains on the GO surface.

## 3.2. Interaction of GO with siRNA

We previously proved that non-functionalized GO is able to adsorb siRNA molecules and that this interaction is driven by the oxygenated groups present on the GO surface.²⁴ When GO is functionalized with PEI, the interaction is guided by the polymer chains and the residual oxygenated groups rather act to hamper the siRNA complexation. First, the complexation of siRNA with the non-functionalized GOs and GOL series and their derivatives, functionalized with PEI, was investigated using a gel retardation assay. For comparison with the series of GOL, we used the same mass ratio of GO/siRNA at 0, 50, 100, 150, 200 and 300. The amount of free siRNA molecules was then estimated by comparing the fluorescence signal between the reference (containing only siRNA) and the other complexation ratios as shown in Fig. S7 (in the ESI†) and in our previous work.²⁴ In both the series of GO, the presence of PEI was able to induce a higher complexation capacity in comparison with the starting GO. Additional HPLC analyses (Fig. S8 in the ESI†) proved that there is negligible denaturation of the duplex after the interaction of siRNA with GOs.

<figure><img src="image_6.png" /></figure>
Adsorption of nucleic acids onto GO is a reversible process, therefore DNA or RNA molecules can easily adsorb onto and desorb from the GO surface (Fig. 1a).²⁸

Similarly, siRNA can adsorb and desorb continuously from GO. To clarify the supramolecular interaction of GO with siRNA molecules, and in particular to understand if GO can alter the conformation of the native siRNA, we first studied the GO siRNA interaction *via* directly mixing the GOs with siRNA at a mass ratio of 2. The siRNA conformational changes were followed using CD (Fig. 1b). This mass ratio was the maximum we could load in the CD cuvette without reaching absorbance saturation and still appreciating the siRNA eventual changes. Surprisingly, an intense bathochromic shift and a clear decrease of the siRNA signal at 264 nm were observed after 2 hours of incubation. This change cannot be ascribed to a substantial adsorption of siRNA onto the GO surface. Indeed, as proved by electrophoresis, good complexation occurs at a much higher mass ratio (Fig. S7 in the ESI†). We can attribute this relevant change in the CD spectral characteristics of siRNA to the dynamic interaction of GO with the duplex. Based on these initial results, we decided to understand what would happen to siRNA molecules under real complexation conditions at much higher GO concentrations. For this purpose, we had to overcome some spectroscopic characteristics of GO: for instance, GO displays a high absorbance below 300 nm in the UV-Vis spectra.²⁹ In addition, GO is a

good acceptor that can efficiently quench dyes and therefore may interfere with many optical spectroscopies. Such interference makes the study of the interaction between GO and other molecules complicate. For these reasons, we decided to investigate the siRNA conformational changes after removing the GO from the solution.

More precisely, after performing the incubation of siRNA with GO, we filtered the GO complex and collected the free siRNA molecules. With this method, we were able to collect and analyze the siRNA molecules in dynamic equilibrium with the GO materials after the incubation, and therefore to indirectly evaluate the siRNA/GO interaction (Fig. 1a). Initially, we optimized the conditions in order to avoid the passage of the different GO and GO-PEI conjugates through the filters (data not shown), measuring the absorbance at 230 nm of each GO dispersion after filtration. In addition, we demonstrated that siRNA molecules are able to easily pass through the filters by measuring their absorbance at 260 nm before and after filtration. Filtered siRNA solutions have also been used as a reference for all the experiments to avoid any effect of this treatment on the siRNA conformational stability. The GO/siRNA mass ratio was another crucial parameter to take into consideration. Indeed, a low mass ratio may not induce significant changes in the siRNA structure, while a too high mass ratio would favor the complexation leaving a very low amount of free siRNA passing through the filter, likely not detectable by UV-Vis. Generally, the GO/siRNA mass ratio used for *in vitro* experiments is between 10 and 50.³⁰ We decided to perform our experiments at a mass ratio of 20. This value reflects a good compromise between the complexing ratios found in the literature and the scope of our study. Only rGO-L-PEI was used at a mass ratio of 5 because of its high siRNA complexation ability.

Considering all these parameters, we initially analyzed the UV-Vis spectra of free siRNA after complexing with different GO materials. The absorbance bands of dsRNA are very sensitive to intramolecular H-bonding cleavage.³¹ In particular, it was reported that the nucleotide unpairing in dsRNA nucleobases induces a hyperchromic effect on the band centered at 260 nm that can be easily detected *via* UV-Vis spectroscopy. To study if our GO materials were able to induce unpairing of nucleobases, we used siRNA labeled with the Yakima Yellow (YY) dye.

The calibration curve of siRNA was obtained using the YY absorbance at 522 nm and the nucleobase absorbance at 260 nm (Fig. S9 in the ESI†). The YY absorbance is proportional to the real concentration of siRNA molecules in solution while the siRNA absorbance at 260 nm may be affected by the base unpairing.³¹ After interaction with the different GO materials, the free siRNA was collected and analyzed by UV-Vis. The concentration of free siRNA was measured using the YY absorbance. The hyperchromicity was calculated considering the percentage of increase of the siRNA absorbance at 260 nm after making contact with GO and the siRNA absorbance, at the same concentration, estimated from the YY calibration curve. Fig. 2 clearly shows the hyperchromic effect

<figure><img src="image_7.png" /><figcaption>**Fig. 1** (a) Scheme of the dynamic equilibrium between the adsorption and desorption of siRNA onto the GO surface. (b) CD spectra of the siRNA mixed with GOs recorded at different time points.</figcaption></figure>

<figure><img src="image_8.png" /></figure>
<figure><img src="image_9.png" /></figure>

<figure><img src="image_10.png" /><figcaption>Fig. 2 UV-Vis spectra at the same concentration (corresponding to the same absorbance intensity at 522 nm) of the starting siRNA (black line), siRNA after incubation with GOs (dashed-dotted red line) and siRNA after incubation with rGOs-PEI (dotted green line).</figcaption></figure>

occurring when siRNA is in contact with GOs, while the
functionalization with PEI does not affect the intensity of the
maximum at 260 nm. A similar trend was also observed for the
GO<sub>L</sub> series (data not shown).

The data, obtained from the UV-Vis analysis, for the
different GO materials are summarized in Fig. 3. Non-functio-
nalized small GO series (GOs, rGOs and rGOs-O3) induced a
high hyperchromicity reaching intensities higher than 55%,
without an appreciable difference among them (Fig. 3a).

Similar hyperchromicity was observed by measuring the
solution after 6 hours from the filtration indicating that the
damage on siRNA induced by the GOs series is permanent
(not shown). PEI functionalization of small GO samples was
able instead to remarkably reduce the hyperchromic effect.
Similar results were found for the large GO samples. Non-func-
tionalized GO<sub>L</sub>, rGO<sub>L</sub> and rGO<sub>L</sub>-O3 showed a hyperchromic
effect higher than 25% (Fig. 3b). Even in this case, the hyper-
chromic effect was almost completely suppressed after PEI
functionalization. On comparison of the non-functionalized
GOs and GO<sub>L</sub> samples, we can see that small GO destabilizes
the double strands of siRNA more than large GO. This behav-
ior can be attributed mainly to the effect of size. Indeed, it has
already been demonstrated that small GO can intercalate into
DNA breaking the H-bonds inside the double strands.<sup>21,22</sup>
Most probably, smaller GO flakes can intercalate more easily
into DNA nucleobases than larger GO, thus inducing more
damage on the double strand structure. There are no evident
trends comparing the amount of oxygenated groups on the GO
surface. Intercalation seems instead driven by the GO size.

Interestingly, PEI functionalized GO samples exhibit a neg-
ligible H-bonding cleavage with a hyperchromic percentage
lower than 5%. This effect is likely due to the direct interaction
of PEI chains that protect the integrity of the siRNA double
strand.<sup>24</sup>

To better elucidate the mechanism of the interaction
between the small and large GO materials, we next tested the

<figure><img src="image_11.png" /><figcaption>Fig. 3 Hyperchromicity values of siRNA at 260 nm after incubation with the different GO conjugates. The reported data are obtained from two sets of measurements.</figcaption></figure>

integrity of free siRNA using FRET probes. For this characteriz-
ation, we used a double strand siRNA (termed 5'-5') with one
strand labeled at the 5' position with Alexa Fluor®546 (donor)
and the other strand labeled at the 5' position with Alexa
Fluor®647 (acceptor), respectively. As a donor alone, we used a
siRNA functionalized at the 5' position with Alexa Fluor®546.
With this donor/acceptor pair we were able to estimate the
5'-5' distance (longitudinal distance) of the siRNA chain
(Table 2). Another important information was to understand if
the strand to strand distance may be affected by the GO inter-
action. For these sets of experiments, we decided to use a
second double strand siRNA (termed 3'-5') labeled at the 5'
position with Cy®3 (donor) and the other strand marked at the
3' position with Cy®5 (acceptor), respectively. As a donor
alone, we used a dsRNA functionalized at the 5' position with
Cy®3 (Table 2). Each FRET pair and the solution of donor
alone have been incubated with GO at a GO/siRNA mass ratio
of 20. After 30 min, the solutions were filtered and analyzed
via UV-Vis and fluorescence spectroscopy techniques (Fig. S10
<table><caption>**Table 2** Distances measured via FRET on siRNA after interaction with the different GO: 3'–5' and 5'–5' distance corresponds to the distance between Alexa Fluor®546/Alexa Fluor®647 and Cy®3/Cy®5 labeled siRNA pairs, respectively</caption><thead><tr><th>Small GO</th><th>5'-5' distance (nm)</th><th>3'-5' distance (nm)</th><th>Large GO</th><th>5'-5' distance (nm)</th><th>3'-5' distance (nm)</th></tr></thead><tbody><tr><td>siRNA</td><td>8.2 ± 0.1</td><td>2.7 ± 0.1</td><td>siRNA</td><td>8.2 ± 0.1</td><td>2.7 ± 0.1</td></tr><tr><td>GO<sub>S</sub></td><td>11.0 ± 0.3*</td><td>5.5 ± 0.7*</td><td>GO<sub>L</sub></td><td>6.9 ± 0.5</td><td>2.9 ± 0.1</td></tr><tr><td>GO<sub>S</sub>-PEI</td><td>7.6 ± 0.1</td><td>2.5 ± 0.1</td><td>GO<sub>L</sub>-PEI<sup>a</sup></td><td>7.5 ± 0.1</td><td>2.6 ± 0.1</td></tr><tr><td>rGO<sub>S</sub></td><td>10 ± 1*</td><td>4 ± 1*</td><td>rGO<sub>L</sub></td><td>8.0 ± 0.3*</td><td>2.7 ± 0.2</td></tr><tr><td>rGO<sub>S</sub>-PEI</td><td>7.4 ± 0.3</td><td>2.7 ± 0.1</td><td>rGO<sub>L</sub>-PEI</td><td>7.6 ± 0.1</td><td>2.6 ± 0.1</td></tr><tr><td>rGO<sub>S</sub>-O<sub>3</sub></td><td>9 ± 1</td><td>3.0 ± 0.3</td><td>rGO<sub>L</sub>-O<sub>3</sub></td><td>7.6 ± 0.2*</td><td>2.7 ± 0.1</td></tr><tr><td>rGO<sub>S</sub>-O<sub>3</sub>-PEI</td><td>7.5 ± 0.1</td><td>2.6 ± 0.1</td><td>rGO<sub>L</sub>-O<sub>3</sub>-PEI</td><td>7.5 ± 0.1</td><td>2.6 ± 0.1</td></tr></tbody><tfoot><tr><td colspan="6"><sup>a</sup> GO/siRNA mass ratio corresponds to 5. *p value <0.05.</td></tr></tfoot></table>

in the ESI†). FRET efficiency (E) was calculated using eqn (1) and (2) given in the ESI.†$^{32}$. The Förster radius was assumed to be 3.8 nm for the couple Cy®3/Cy®5$^{32}$ and 7.4 nm for the Alexa Fluor®546/Alexa Fluor®647 as reported from the provider.$^{33}$ Since the FRET efficiency is inversely proportional to the sixth power of the distance R between the donor and the acceptor, the two fluorescent molecules should be in close proximity to allow significant energy transfer. The measured distances are given in Table 2.

A siRNA molecule can be represented as a nanometric rod with an average size below 10 nm in length and approximately 2 nm in diameter.$^{34}$ FRET measurement of native siRNA used in our experiments showed a longitudinal distance of 8.2 ± 0.1 nm (measuring the 5'–5' distance) and a strand to strand distance of 2.7 ± 0.1 nm (measuring the 3'–5' distance) (Table 2). These values are in full agreement with those found in the literature.$^{34}$ The non-functionalized small GO samples display a general enhancement of both lateral and longitudinal distances. In particular, the 5'–5' distance was 11.0 ± 0.3, 10 ± 1 and 9 ± 1 nm for GO<sub>S</sub>, rGO<sub>S</sub> and rGO<sub>S</sub>-O<sub>3</sub>, respectively. The 3'–5' distance also increased to 5.5 ± 0.7 nm for GO<sub>S</sub>, and to 4 ± 1 and 3.0 ± 0.3 nm for rGO<sub>S</sub> and rGO<sub>S</sub>-O<sub>3</sub>, respectively. No significant differences were instead observed for PEI functionalized small GO<sub>S</sub> in the CC distance, meanwhile the 5'–5' distance appears a bit shorter (i.e. 0.6–0.8 nm) (Table 2). In the case of large GO<sub>L</sub>, less evident changes in the strand-to-strand and the longitudinal distances could be observed. The data for GO<sub>L</sub>, rGO<sub>L</sub> and rGO<sub>L</sub>-O<sub>3</sub> correspond to 6.9 ± 0.5, 8.0 ± 0.3 and 7.6 ± 0.2 nm for the 5'–5' distances, and to 2.9 ± 0.1, 2.7 ± 0.2 and 2.7 ± 0.1 nm for the 3'–5' distances, respectively. Even in the case of large GO<sub>L</sub> flakes functionalized with PEI, the interaction with siRNA did not affect the lateral distances, but slightly decreases the longitudinal distance (7.5 ± 0.1 nm for GO<sub>L</sub>-PEI and rGO<sub>L</sub>-O<sub>3</sub>-PEI, and 7.6 ± 0.1 nm for rGO<sub>L</sub>-PEI). FRET distances have been calculated from an average of at least two different experiments in each measurement. To validate our data, we performed statistical treatment by comparing the FRET distances found on native siRNA with the distances obtained from siRNA incubated with the most representative non-functionalized GO materials. The results confirm that the measured FRET differences are statistically significant.

As mentioned before, hyperchromicity analysis gave us some information about the H-bond breaking, while FRET helped to understand the displacement of the RNA strands after the interaction with GO. However, neither FRET nor UV allows us to describe the secondary structure of the siRNA. To deeply understand the nature of the structural modifications induced by GO, we decided to characterize the siRNA conformation after incubating with GO using circular dichroism. In Fig. 4, we show the CD spectra of the siRNA after the process of incubation with GO and filtration.

The native siRNA CD spectrum (Fig. 4, black lines) shows a positive band at 264 nm and a negative band at 210 nm, which are typical of an A-helix conformation.$^{35,36}$ In particular, the positive band at 264 nm is associated with the stacking interaction between the planar base pairs and the helical structure of the RNA that induces a chiral environment on the nucleobases, while the negative band centered at 210 nm is related to the A-helix backbone conformation.$^{37}$ After contact with small GO<sub>S</sub> flakes, several changes in the CD spectra can be observed (Fig. 4a). The positive band at 264 nm decreases in intensity with a bathochromic shift of the maximum, while the negative band centered at 210 nm is remarkably reduced in intensity. Comparing the shifts of the positive band, the siRNA signal undergoes a shift of ≈15 nm after the interaction with GO<sub>S</sub>, while with rGO<sub>S</sub> and rGO<sub>S</sub>-O<sub>3</sub> the shifts are about 7 nm. This behavior is typically related to the siRNA unfolding and denaturation.$^{35,38}$ Instead, the interaction of siRNA with PEI functionalized GO<sub>S</sub> does not alter the polynucleotide secondary structure (Fig. 4b) showing only a small decrease of the band at 210 nm. In the case of non-functionalized GO<sub>L</sub> samples, the CD spectra appear different (Fig. 4c). Once again, the siRNA secondary structure is affected. We measured an enhancement of the band at 264 nm without any significant shift and a sensible decrease of the negative band at 210 nm. It has been reported before that in duplex RNA, the CD intensity near 260 nm is inversely correlated with the helical winding angle.$^{39}$ Similarly, the increase in the CD intensity induced by the interaction of the GO<sub>L</sub> series can be associated with a reduction of the winding angle of the siRNA helix, leading to a modification of the structure in close relation with the FRET analysis. siRNA treated with the PEI functionalized large GO<sub>L</sub>

<figure><img src="image_12.png" /></figure>
<figure><img src="image_13.png" /><figcaption>Fig. 4 CD spectra of siRNA after incubation and filtration with a series of: (a) GO<sub>S</sub>, (b) GO<sub>S</sub>-PEI, (c) GO<sub>L</sub>, and (d) GO<sub>L</sub>-PEI, respectively.</figcaption></figure>

series presents only small modifications in the 210 nm CD band like in the case of the PEI functionalized small GO<sub>S</sub> materials (Fig. 4d). All data on the siRNA conformation from CD spectroscopy confirmed strong conformational changes due to the interaction with the different non-functionalized GO materials.

Combining the results from hyperchromism, FRET and CD, we can conclude that siRNA presents clear structural modifications after interaction with GO, induced by both small and large sized nanosheets. The nature and the type of interaction are however dependent on the GO size. Comparing the two series of non-functionalized small and large GO, the GO<sub>S</sub> series shows a higher hyperchromicity with an enhancement of the lateral and the longitudinal distances. The changes in these parameters demonstrate unambiguously that smaller GO is able to induce more damage in the siRNA structure than the larger one. It has been already reported that GO causes the cleavage of the DNA duplex.<sup>21</sup> In our study, HPLC analysis (Fig. S8 in the ESI†) showed that the two siRNA strands are still intramolecularly stabilized. In addition, the CD analysis showed that incubation with GO<sub>S</sub> samples sensibly decreases the helicity. These results clearly suggest that double strand denaturation occurs, without necessarily leading to complete strand displacement or duplex breakage.<sup>35,38</sup> On the other hand, the mechanism of interaction is not easy to assess. It has been already supposed that GO can intercalate between the nucleobases.<sup>21</sup> However, this mechanism should be better elucidated since there is a remarkable size difference between

the GO and the siRNA duplex. Besides, the small GO<sub>S</sub> flakes leading to a strong unpairing (confirmed by high hyperchromicity) cause a moderate displacement of the two strands (confirmed by higher FRET distances) and induce a partial transition from the A-helix to the random coil (lower and shifted helicity at 264 nm). This siRNA damage provoked by the GO<sub>S</sub> series does not seem to be induced by simple adsorption but mostly by a partial insertion (from the edges) of the small flakes within the double strand (Fig. 5a). We think that most probably small flake edges are able to interact with the siRNA nucleobases provoking partial interstrand H-bond breaking.

Within the three small GO specimens, GO<sub>S</sub> shows the highest siRNA destabilization ability, while rGO<sub>S</sub>-O<sub>3</sub> induces more alterations in the native structure than rGO<sub>S</sub> (GO<sub>S</sub> > rGO<sub>S</sub>-O<sub>3</sub> > rGO<sub>S</sub>). This trend can be explained if we consider the functional groups present on the GO surface. In particular, this seems to be correlated with the C/O ratio obtained from XPS (Table 1). Destabilization of siRNA with small GO may be triggered by the oxygenated groups. Most probably, these electro-negative groups are able to form polar bonds with the nitrogen nucleobases, destabilizing the H-bond between the double strands. In the case of the large GO series, there is a lower destabilization of the interstrand H-bonds (supported by low hyperchromicity) and a general reduction of the 5'-5' distance proved by FRET. On the other hand, CD spectra show an enhancement of the helicity at 264 nm due to a clear interaction with the large GO<sub>L</sub> flakes. Most probably, large GO<sub>L</sub> is too big to efficiently intercalate between the nucleotides, but it
<figure><img src="image_14.png" /><figcaption>Fig. 5 Cartoon illustrating the possible interactions and conformational changes of (a) GOs and (b) GO~L~ with the siRNA molecule.</figcaption></figure>

interacts with the RNA groove causing a decrease of the winding angle, thus altering the structure of the double A-helix (Fig. 5b).

The reduction of the winding angle allows the increase of the number of bases per turn in the helix. This conformational change causes the enhancement of the base to base stacking (increasing the CD band at 264 nm), alters the helix backbone structure (decreasing the CD band at 210 nm), and provokes a helical length shrinking (as shown by FRET analysis). In the case of protein interaction with RNA, it has been proven, by solving the crystal structure of the complex, that the distortion from the ideal RNA A-helix is due to an interaction on the major groove without any contact with the nucleotides.⁴⁰ For the large GO, there is destabilization of some H-bonds between the strands (Fig. 2), but it is not clear if this behavior is due to a direct interaction of GO with the nucleobases or only with the helix groove. Comparing the differently oxygenated large GO specimens, it appears clear that the rGO~L~O~3~ and rGO~L~ induce more changes in the native siRNA conformation than GO~L~. The latter tendency may be again correlated with the amount of oxygenated groups (Table 1). In particular, it seems that the oxygenated species avoid the siRNA conformational change. Most probably, the siRNA secondary structure alteration induced by large GO flakes is mediated by non-polar interactions such as π-π stacking. Interestingly, PEI functionalization of both large and small GO does not induce significant changes in the siRNA structure. Only small backbone conformational alterations (slight decrease of 210 nm CD band) were evidenced, most probably due to the interaction between the positively charged PEI chains and the negative phosphate groups in the siRNA skeletal structure.⁴¹ However, these small changes are not yet clear. We hypothesized that the ionic interaction of PEI chains with the phosphate groups partially alters the siRNA backbone geometry causing a small

A-helix bending that provokes a decrease of the band at 210 nm in the CD spectra and the small shortening of the 5'-5' distance as seen by FRET. Nevertheless, these siRNA small secondary structure modifications have already been described in the literature and should not alter the siRNA biological activity *in vitro* or *in vivo*.⁴¹

## 4. Conclusions

In this work, we analyzed the siRNA structure alterations induced by GO. We performed a systematic study by varying the size and the oxidation level of GO from two different sources. In addition, to observe the effect of amino groups we tested different GO materials after PEI functionalization, and complexed with siRNA molecules. Using a mild filtration protocol, we were able to separate free siRNA molecules from GO flakes after their incubation and to assess the conformational damage *via* UV-Vis, fluorescence and CD spectra. A deep understanding of the interaction of siRNA and GO is crucial for its future applications. Our results indicate that the alteration of the siRNA structure is strongly mediated by the GO size. Indeed, small GO seems to intercalate between the double strands and induce severe damage on the RNA conformation. Large GO instead seems to basically reduce the A-helix pitch. In addition, we proved that even after 6 hours the siRNA was not able to recover its native structure. Interestingly, all the PEI functionalized GO materials did not show significant conformational alterations. We believe that the full comprehension of the supramolecular interactions between GO and siRNA is essential for an effective GO application in nanomedicine. Depending on the size, GO can efficiently unwind, displace and partially denature the double siRNA strands, thus likely altering its biological activity. For these reasons, we wish to suggest not to use non-functionalized GO in gene delivery or silencing. On the other hand, the results also demonstrate that PEI functionalized GO can overcome the partial denaturation effect of GO after interaction with siRNA, and retain the native oligonucleotide conformation. This protecting activity together with its high siRNA complexing capacity makes GO-PEI a promising material for gene delivery and silencing applications.

## Conflicts of interest

All the authors declare no conflicts of interest with this work.

## Acknowledgements

The authors gratefully acknowledge the financial support from the EU H2020-Adhoc-2014-20 GrapheneCore1 (no. 696656) and from the Agence Nationale de la Recherche (ANR) through the LabEx project Chemistry of Complex Systems (ANR-10-LABX-0026_CSC). This work was partly supported by the Centre National de la Recherche Scientifique (CNRS), the

<figure><img src="image_15.png" /></figure>
International Center for Frontier Research in Chemistry (icFRC), the JST PRESTO, and the JSPS KAKENHI (Science of Atomic Layers (SATL), Grant number 16H00915). N. D. Q. C. is grateful to Honda foundation for mobility grant to Japan. The authors thank Dr Serana Bernacchi for help in fluorescence spectroscopy measurements, Fanny Bonachera for preparing the GO models and Adriano Aloisi for HPLC analyses.

## References

1. I. M. Verma and N. Somia, *Nature*, 1997, **389**, 239–242.

2. H. Yin, R. L. Kanasty, A. A. Eltoukhy, A. J. Vegas, J. R. Dorkin and D. G. Anderson, *Nat. Rev. Genet.*, 2014, **15**, 541–555.

3. G. J. Hannon, *Nature*, 2002, **418**, 244–251.

4. A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver and C. C. Mello, *Nature*, 1998, **391**, 806–811.

5. D. M. Dykxhoorn, D. Palliser and J. Lieberman, *Gene Ther.*, 2006, **13**, 541–552.

6. S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber and T. Tuschl, *Nature*, 2001, **411**, 494–498.

7. K. A. Whitehead, R. Langer and D. G. Anderson, *Nat. Rev. Drug Discovery*, 2009, **8**, 129–138.

8. M. Nurunnabi, K. Parvez, V. Revuri, H. A. Khan, X. Feng and Y. Lee, *RSC Adv.*, 2015, **5**, 42141–42161.

9. Y. Zhang, T. R. Nayak and W. Cai, *Nanoscale*, 2012, **4**, 3833–3842.

10. K. Yang, L. Feng, X. Shi and Z. Liu, *Chem. Soc. Rev.*, 2013, **42**, 530–547.

11. R. Kurapati, J. Russier, M. A. Squillaci, E. Treossi, C. Ménard-Moyon, A. E. Del Rio-Castillo, E. Vazquez, P. Samori, V. Palermo and A. Bianco, *Small*, 2015, **11**, 3985–3994.

12. D. R. Dreyer, S. Park, C. W. Bielawski, R. S. Ruoff, J. M. Tour, K. Müllen, A. Ivaska, R. G.-S. Goh, R. H. Friend, A. T. S. Wee, P. K.-H. Ho, D. Chen and R. S. Ruoff, *Chem. Soc. Rev.*, 2010, **39**, 228–240.

13. Y. Yang, A. M. Asiri, Z. Tang, D. Du and Y. Lin, *Biochem. Pharmacol.*, 2013, **16**, 365–373.

14. K. V. Krishna, C. Ménard-Moyon, S. Verma and A. Bianco, *Nanomedicine*, 2013, **8**, 1669–1688.

15. J. Lee, Y. Yim, S. Kim, M. H. Choi, B. S. Choi, Y. Lee and D. H. Min, *Carbon*, 2016, **97**, 92–98.

16. L. Tang, Y. Wang and J. Li, *Chem. Soc. Rev.*, 2015, **44**, 6954–6980.

17. H. Lei, L. Mi, X. Zhou, J. Chen, J. Hu, S. Guo and Y. Zhang, *Nanoscale*, 2011, **3**, 3888–3892.

18. M. Liu, H. Zhao, S. Chen, H. Yu and X. Quan, *Chem. Commun.*, 2012, **48**, 564–566.

19. L. Tang, H. Chang, Y. Liu and J. Li, *Adv. Funct. Mater.*, 2012, **22**, 3083–3088.

20. X. Zhao, *J. Phys. Chem. C*, 2011, **115**, 6181–6189.

21. H. Ren, C. Wang, J. Zhang, X. Zhou, D. Xu, J. Zheng, S. Guo and J. Zhang, *ACS Nano*, 2010, **4**, 7169–7174.

22. B. Zheng, C. Wang, C. Wu, X. Zhou, M. Lin, X. Wu, X. Xin, X. Chen, L. Xu, H. Liu, J. Zheng, J. Zhang and S. Guo, *J. Phys. Chem. C*, 2012, **116**, 15839–15846.

23. N. Morimoto, T. Kubo and Y. Nishina, *Sci. Rep.*, 2016, **6**, 21715.

24. N. D. Q. Chau, G. Reina, J. Raya, I. A. Vacchi, C. Ménard-Moyon, Y. Nishina and A. Bianco, *Carbon*, 2017, **122**, 643–652.

25. I. A. Vacchi, C. Spinato, J. Raya, A. Bianco and C. Ménard-Moyon, *Nanoscale*, 2016, **8**, 13714–13721.

26. S. Makharza, G. Cirillo, A. Bachmatiuk, I. Ibrahim, N. Ioannides, B. Trzebicka, S. Hampel and M. H. Rümmeli, *J. Nanopart. Res.*, 2013, **15**, 2099.

27. N. Morimoto, T. Kubo and Y. Nishina, *Sci. Rep.*, 2016, **6**, 21715.

28. C. H. Lu, H. H. Yang, C. L. Zhu, X. Chen and G. N. Chen, *Angew. Chem., Int. Ed.*, 2009, **48**, 4785–4787.

29. J. Shang, L. Ma, J. Li, W. Ai, T. Yu and G. G. Gurzadyan, *Sci. Rep.*, 2012, **2**, 792.

30. G. Shim, M.-G. Kim and J. Y. Park, *Adv. Drug Delivery Rev.*, 2016, **105**, 205–227.

31. D. E. Draper, Y. Xing and L. G. Laing, *J. Mol. Biol.*, 1995, **249**, 231–238.

32. M. Massey, W. R. Algar and U. J. Krull, *Anal. Chim. Acta*, 2006, **568**, 181–189.

33. https://www.thermofisher.com/uk/en/home/references/molecular-probes-the-handbook/tables/r0-values-for-some-alexa-fluor-dyes.html.

34. J. M. Barichello, S. Kizuki, T. Tagami, L. A. L. Soares, T. Ishida, H. Kikuchi and H. Kiwada, *Int. J. Pharm.*, 2012, **430**, 359–365.

35. J. Kypr, I. Kejnovská, D. Renciuk and M. Vorlícková, *Nucleic Acids Res.*, 2009, **37**, 1713–1725.

36. I. S. Cho, J. Kim, D. H. Lim, H.-C. Ahn, H. Kim, K.-B. Lee and Y. S. Lee, *Biotechnol. Lett.*, 2008, **30**, 1901–1908.

37. R. W. Woody, *Methods Enzymol.*, 1995, **246**, 34–71.

38. D. J. Phillips and A. M. Bobst, *Biochem. Biophys. Res. Commun.*, 1972, **47**, 150–156.

39. J. W. Ucci, Y. Kobayashi, G. Choi, A. T. Alexandrescu and J. L. Cole, *Biochemistry*, 2007, **46**, 55–65.

40. J. M. Ryter and S. C. Schultz, *EMBO J.*, 1998, **17**, 7505–7513.

41. O. M. Merkel, A. Beyerle, D. Librizzi, A. Pdestroff, T. M. Behr, B. Sproat, P. J. Barth and T. Kissel, *Mol. Pharm.*, 2009, **6**, 1246–1260.

<figure><img src="image_16.png" /></figure>